Dr. Reddy's Laboratories Ltd. Financials: Quarterly Results
Revenue
7991.6
Cr.
PAT
216.70
Cr.
EBITDA
300.80
Cr.
Dr. Reddy's Laboratories Ltd. Q4FY26 Financial Metrics
| Indicator | Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 7516.20 | 8727 | 8804.90 | 8545.20 | 8506 |
| Total Income From Operations (Cr.) | 7546.40 | 8753.40 | 8828.30 | 8572.10 | 8528.40 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | 300.80 | 1635.30 | 1829.20 | 1987.80 | 2065.30 |
| P/L Before Exceptional Items & Tax (Cr.) | 195.10 | 1540.90 | 1738.50 | 1904.80 | 1999.70 |
| P/L After Tax from Ordinary Activities (Cr.) | 216.70 | 1187.30 | 1330.50 | 1409.70 | 1581.20 |
| Net Profit/Loss For the Period (Cr.) | 216.70 | 1187.30 | 1330.50 | 1409.70 | 1581.20 |
| Basic EPS | 2.65 | 14.53 | 16.18 | 17.04 | 19.12 |
FAQs
Dr. Reddy's Laboratories Ltd. announced its quarterly results for Q4 FY2026 on May 12, 2026.
In Q4 FY2026, Dr. Reddy's Laboratories Ltd. are as follows:
Revenue: ₹7991.6 crore
Net Profit: ₹216.70 crore.
For Q4 FY2026, Dr. Reddy's Laboratories Ltd. posted ₹7991.6 crore in revenue and ₹216.70 crore in net profit.
Past quarterly results for Dr. Reddy's Laboratories Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.